Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Endometriosis (Triptorelin - Endometriosis)

Records returned : 7 (on 05 Dec 2025 at 17:27:23). Return to search results for ' Endometriosis '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off Label

Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

SPC

View the treatment summary for {padindicationname} on https://www.medicines.org.uk

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Triptorelin

Drug:

Triptorelin

Indication :

Endometriosis

Status :

Blue

Formulations :

Injection

Restrictions / Comments:

Important

The specialist team should initiate treatment and administer the 1st injection prior to transfer of care.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

2. Dienogest

Drug:

Dienogest

Indication :

Endometriosis

Status :

Blue

Formulations :

Not Specified

Restrictions / Comments:

Important

To be initiated and first 6 months treatment to be supplied by a specialist

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

3. Goserelin acetate

Drug:

Goserelin acetate

Indication :

Endometriosis

Status :

Blue

Formulations :

Implant
Pre-filled syringe

Restrictions / Comments:

Important

The specialist team should initiate treatment and administer the 1st injection prior to transfer of care.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

4. Leuprorelin acetate

Drug:

Leuprorelin acetate

Indication :

Endometriosis

Status :

Blue

Formulations :

Injection

Restrictions / Comments:

Important

The specialist team should initiate treatment and administer the 1st injection prior to transfer of care.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

5. Linzagolix

Drug:

Linzagolix

Indication :

Endometriosis

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

The specialist team should initiate treatment and prescribe at least 1 month of linzagolix prior to transfer of care.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

SPC

6. Relugolix with estradiol and norethisterone acetate

Drug:

Relugolix with estradiol and norethisterone acetate

Indication :

Endometriosis

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

At least 1 month prescribing by the specialist prior to transfer of care.

A DXA scan is recommended after the first 52 weeks of treatment to verify that the patient does not have an unwanted degree of BMD loss, that exceeds the benefit of treatment. This DXA scan will be organised & performed by the specialist team responsible for the ongoing care of the patient

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :